Berkeley, Inc Viatris Inc Transaction History

Berkeley, Inc

$193 Billion
Q4 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 04, 2025	SELL	$8.77 - $10.85 $158,965 - $196,667	-18,126 Closed	0 $0
Q3 2023 Mar 28, 2025	SELL	$9.59 - $11.35 $27,734 - $32,824	-2,892 Reduced 13.76%	18,126 $179 Million
Q3 2023 Mar 04, 2025	SELL	$9.59 - $11.35 $27,734 - $32,824	-2,892 Reduced 13.76%	18,126 $179 Million
Q2 2023 Mar 28, 2025	BUY	$9.02 - $10.29 $1,235 - $1,409	137 Added 0.66%	21,018 $210 Million
Q2 2023 Mar 04, 2025	BUY	$9.02 - $10.29 $1,235 - $1,409	137 Added 0.66%	21,018 $210 Million
Q1 2023 Mar 28, 2025	SELL	$9.2 - $12.26 $10,754 - $14,331	-1,169 Reduced 5.3%	20,881 $201 Million
Q1 2023 Mar 04, 2025	SELL	$9.2 - $12.26 $10,754 - $14,331	-1,169 Reduced 5.3%	20,881 $201 Million
Q4 2022 Mar 28, 2025	BUY	$8.72 - $11.56 $192,276 - $254,898	22,050 New	22,050 $245 Million
Q4 2022 Mar 04, 2025	BUY	$8.72 - $11.56 $1,142 - $1,514	131 Added 0.6%	22,050 $245 Million
Q3 2022 Mar 28, 2025	SELL	$8.48 - $11.13 $2,925 - $3,839	-345 Reduced 1.55%	21,919 $187 Million
Q3 2022 Mar 04, 2025	SELL	$8.48 - $11.13 $2,925 - $3,839	-345 Reduced 1.55%	21,919 $187 Million
Q2 2022 Mar 28, 2025	SELL	$9.95 - $12.27 $6,557 - $8,085	-659 Reduced 2.87%	22,264 $233 Million
Q2 2022 Mar 04, 2025	SELL	$9.95 - $12.27 $6,557 - $8,085	-659 Reduced 2.87%	22,264 $233 Million
Q1 2022 Mar 28, 2025	SELL	$9.81 - $15.4 $15,489 - $24,316	-1,579 Reduced 6.44%	22,923 $249 Million
Q1 2022 Mar 04, 2025	SELL	$9.81 - $15.4 $15,489 - $24,316	-1,579 Reduced 6.44%	22,923 $249 Million
Q4 2021 Mar 28, 2025	SELL	$12.09 - $14.68 $387,943 - $471,051	-32,088 Reduced 56.7%	24,502 $332 Million
Q4 2021 Mar 04, 2025	SELL	$12.09 - $14.68 $387,943 - $471,051	-32,088 Reduced 56.7%	24,502 $332 Million
Q3 2021 Mar 28, 2025	SELL	$13.25 - $15.13 $22,935 - $26,190	-1,731 Reduced 2.97%	56,590 $767 Million
Q3 2021 Mar 04, 2025	SELL	$13.25 - $15.13 $22,935 - $26,190	-1,731 Reduced 2.97%	56,590 $767 Million
Q2 2021 Mar 28, 2025	SELL	$12.97 - $16.15 $45,070 - $56,121	-3,475 Reduced 5.62%	58,321 $833 Million
Q2 2021 Mar 04, 2025	SELL	$12.97 - $16.15 $45,070 - $56,121	-3,475 Reduced 5.62%	58,321 $833 Million
Q1 2021 Mar 28, 2025	BUY	$13.59 - $18.54 $839,807 - $1.15 Million	61,796 New	61,796 $863 Million
Q1 2021 Mar 04, 2025	BUY	$13.59 - $18.54 $325,290 - $443,773	23,936 Added 63.22%	61,796 $863 Million
Q4 2020 Mar 28, 2025	BUY	$14.3 - $18.74 $541,398 - $709,496	37,860 New	37,860 $709 Million
Q4 2020 Feb 28, 2025	BUY	$14.3 - $18.74 $541,398 - $709,496	37,860 New	37,860 $709 Million

Others Institutions Holding VTRS

# of Institutions

1,137

Shares Held

989M

Call Options Held

2.34M

Put Options Held

2.21M

Vanguard Group Inc Valley Forge, PA

142M
Shares

$1.07 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

92.7M
Shares

$701 Million
0.02% of portfolio
State Street Corp Boston, MA

63.7M
Shares

$482 Million
0.03% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

62.6M
Shares

$473 Million
4.62% of portfolio
Price T Rowe Associates Inc Baltimore, MD

58.7M
Shares

$444 Million
0.08% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $9.17B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley, Inc with notifications on news.

Account